Application no. and date | 00953387.8 (espacenet) (Federated) (European Patent Register), 20000831 | Patent/reg. no. and date | DK/EP 1214076, 20031119 | Publication date | 20020619 | Priority no. and date | US 386274, 19990831, EP 99202826, 19990831 | EP pub. no. and date |
EP 1214076 20020619 | Effective date | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13342 Berlin, DE | Applicant ref. no. | 22259 DK 01 | Inventor | HEIL, Wolfgang, Münchener Strasse 26/27
D-10825 Berlin, DE, HILMAN, Jürgen, Ugandastrasse 9
D-13351 Berlin, DE, LIPP, Ralph, Holzungsweg 63
D-14169 Berlin, DE, HEITHECKER, Renate, Wolzogenstrasse 15
D-14163 Berlin, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/565 (2006.01) , A61K 31/585 (2006.01) , A61P 15/00 (2006.01) | Title | Farmaceutisk kombination af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel | Int. application no. | IB2000001213 | Int. publication no. | WO2001015701 | Related patent (certificate) | CA 2008 00053 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|